港股一脉阳光（02522）今日盘中大涨5.29%，引起市场广泛关注。分析认为，南向资金连续增持及医疗器械行业政策利好可能是推动股价上涨的主要原因。
据悉，南向资金已连续3个交易日增持一脉阳光股票。3月31日单日增持424.70万股，截至当日收盘，港股通共持有一脉阳光914.90万股，占流通股3.67%。这一持续增持行为显示出投资者对公司前景的信心，可能是推动股价上涨的重要因素之一。
另一方面，国家药监局近期发布的政策也为医疗器械行业带来利好。政策提出要加快推进医用机器人、人工智能医疗器械、高端医学影像设备等领域的基础、通用标准和方法标准等制修订工作。作为医疗器械行业的重要参与者，一脉阳光有望从这一政策中受益，这可能也是刺激投资者信心的因素之一。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.